≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Disorder of external ear, unspecified

DOID EFO Endpoint Browser PheWeb

H8_EXTDISINOTH

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H62*
  • Cause of death: ICD-10 — H62*

2 out of 7 registries used, show all original rules.

1149

4. Check minimum number of events

None

1149

5. Include endpoints

None

1149

6. Filter based on genotype QC (FinnGen only)

1149

Control definitions (FinnGen only)

Control exclude
H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7369 3573 3766
Only index persons 7023 3453 3570
Unadjusted period prevalence (%)
Whole population 0.10 0.10 0.11
Only index persons 0.13 0.13 0.14
Median age at first event (years)
Whole population 57.40 57.69 57.22
Only index persons 57.52 57.75 57.29

-FinnGen-

Key figures

All Female Male
Number of individuals 1149 607 542
Unadjusted period prevalence (%) 0.22 0.21 0.24
Median age at first event (years) 58.67 56.65 60.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1023
Matched controls
10228
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
5134.9
323.0
774
6
A46
ICD-10 Finland
Erysipelas
12.2
238.0
508
763
H62.0
ICD-10 Finland
Otitis externa in bacterial diseases classified elsewhere
965.6
171.1
163
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
13.5
132.0
243
230
H60.8
ICD-10 Finland
Other otitis externa
25.3
81.0
115
51
H60.3
ICD-10 Finland
Other infective otitis externa
29.0
78.4
107
41
J01DB01
ATC
cefalexin; oral
5.2
65.4
942
7072
H62.1*B02.8
ICD-10 Finland
Otitis externa in zoster
657.2
63.5
62
*
H60.1
ICD-10 Finland
Cellulitis of external ear
34.1
58.3
76
24
H60
ICD-10 Finland
Otitis externa
7.6
46.8
114
165
H01
ICPC
Ear pain/earache
4.0
39.3
173
494
H62.2
ICD-10 Finland
Otitis externa in mycoses
+∞
37.7
36
*
H29
ICPC
Ear symptom/complaint other
3.8
35.1
163
485
S76
ICPC
Skin infection other
5.2
34.9
114
240
J01FF01
ATC
clindamycin; systemic
2.4
31.4
344
1780
H62.2*B36.9
ICD-10 Finland
Otomycosis NOS
+∞
28.3
27
*
J01DA01
ATC
[U] cefalexin; systemic
2.1
27.3
680
4972
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
26.5
342
1884
D07AC01
ATC
betamethasone; topical
2.1
25.6
398
2371
UDC00
NOMESCO Finland
Ear microscopy
3.7
25.3
116
338
H62.1*B00.19
ICD-10 Finland
Otitis externa in herpesviral [herpes simplex] infection
+∞
25.1
24
*
S02CA02
ATC
flumetasone and antiinfectives; otic
4.2
23.4
92
234
H70
ICPC
Otitis externa
7.7
22.2
52
71
H04
ICPC
Ear discharge
5.2
21.7
69
141
J01CE08
ATC
benzathine benzylpenicillin; parenteral
13.2
21.3
37
29
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.6
21.2
167
703
J01CE02
ATC
phenoxymethylpenicillin; oral
1.9
21.2
724
5667
B02.8
ICD-10 Finland
Zoster with other complications
34.6
21.2
27
8
H60.0
ICD-10 Finland
Abscess of external ear
49.1
20.2
24
5
H62.2*B44.8
ICD-10 Finland
Otitis externa in aspergillosis
+∞
19.9
19
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
19.3
456
3093
SPAT1255
SPAT
Intravenous administration of medicine
3.4
19.1
96
301
E0000UV
ATC
NA
1.9
18.7
414
2736
H61.0
ICD-10 Finland
Perichondritis of external ear
193.4
18.6
19
*
D07AC13
ATC
mometasone; topical
1.9
17.5
311
1888
D07XC01
ATC
betamethasone, combinations; topical
2.5
17.4
153
683
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.5
17.4
83
250
D07AA02
ATC
hydrocortisone; topical
2.4
17.3
162
746
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
7.7
16.5
38
51
J05AB11
ATC
valaciclovir; oral
2.3
16.2
160
757
H61.2
ICD-10 Finland
Impacted cerumen
4.0
16.1
65
170
N02BE01
ATC
paracetamol; systemic, rectal
2.0
15.9
866
7500
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
15.7
519
3829
H62.2*B37.2
ICD-10 Finland
Otitis externa in candidiasis
+∞
15.7
15
*
D07CC01
ATC
betamethasone and antibiotics; topical
2.3
15.3
150
706
H66.9
ICD-10 Finland
Otitis media, unspecified
3.5
14.0
67
203
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
13.9
191
1041
H62.1
ICD-10 Finland
Otitis externa in viral diseases classified elsewhere
+∞
13.6
13
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
13.4
112
484
R50.9
ICD-10 Finland
Fever, unspecified
2.1
13.2
152
769
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
12.4
13.1
23
19
Z3231
NOMESCO Finland
Registered nurse
1.8
12.8
278
1778
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
12.2
238
1468
TDA90
NOMESCO Finland
Removal wax from ear
8.3
12.1
26
32
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.3
11.8
111
511
J01MA02
ATC
ciprofloxacin; systemic
1.6
11.8
383
2741
S29
ICPC
Skin symptom/complaint other
2.0
11.7
173
963
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
16.6
11.7
18
11
E000001
ATC
NA
1.8
11.6
214
1291
G51.0
ICD-10 Finland
Bell palsy
4.4
11.5
41
97
H13
ICPC
Plugged feeling ear
1.9
11.4
176
997
L20.0
ICD-10 Finland
Besnier prurigo
2.8
11.4
74
277
SPAT1263
SPAT
Sampling
1.6
11.1
410
3021
R06AE07
ATC
cetirizine; oral
1.6
11.0
413
3050
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
10.5
188
1119
H62.4*L01.0
ICD-10 Finland
Otitis externa in impetigo
+∞
10.4
10
*
J01CA04
ATC
amoxicillin; systemic
1.6
10.3
784
6827
L73.2
ICD-10 Finland
Hidradenitis suppurativa
8.9
10.3
21
24
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
10.2
207
1284
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.7
10.0
43
121
AA1AD
NOMESCO Finland
CT of head and brain
1.7
9.9
230
1485
L03.2
ICD-10 Finland
Cellulitis of face
9.7
9.8
19
20
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
9.6
132
715
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.9
9.5
135
741
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
9.5
87
394
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.8
9.4
38
102
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.7
9.0
38
106
G47.3
ICD-10 Finland
Sleep apnoea
1.7
8.9
217
1417
Z2221
NOMESCO Finland
Medical doctor
1.6
8.8
265
1827
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
8.8
254
1733
H61.8
ICD-10 Finland
Other specified disorders of external ear
14.2
8.7
14
10
H02AB06
ATC
prednisolone; systemic
1.5
8.7
438
3411
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
5.6
8.6
24
44
H60.4
ICD-10 Finland
Cholesteatoma of external ear
27.8
8.5
11
*
D07BC01
ATC
betamethasone and antiseptics; topical
1.9
8.5
127
711
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.5
399
3056
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
8.3
528
4299
ZXA10
NOMESCO Finland
Bilateral
1.7
8.2
173
1079
H81
ICPC
Excessive ear wax
1.8
8.1
148
884
D07AD01
ATC
clobetasol; topical
1.8
8.0
157
957
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
8.0
307
2237
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.0
262
1841
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.6
8.0
34
96
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.7
8.0
52
198
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
8.0
67
291
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
8.0
147
882
DC1AD
NOMESCO Finland
Temporalbone CT
7.3
8.0
18
25
D11AH01
ATC
tacrolimus; topical
7.3
8.0
18
25
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
7.9
269
1908
B02.9
ICD-10 Finland
Zoster without complication
2.5
7.9
61
256
H02AB07
ATC
prednisone; oral
1.8
7.9
134
783
D07AB08
ATC
desonide; topical
1.9
7.8
108
588
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
7.7
131
761
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
7.7
78
371
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.7
318
2354
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.6
193
1268
S06
ICPC
Rash localized
2.4
7.6
62
268
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
7.5
104
566
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
7.4
115
651
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
7.4
351
2672
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
7.4
105
577
S01
ICPC
Pain/tenderness of skin
2.7
7.3
47
177
SPAT1254
SPAT
Administration of medicine
1.8
7.3
133
793
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.3
103
564
H620, A499
ICD-10 Finland
NA
+∞
7.3
7
*
M94.1
ICD-10 Finland
Relapsing polychondritis
+∞
7.3
7
*
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.3
223
1539
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
7.2
77
375
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.1
7.2
26
64
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
7.2
145
893
N05AA02
ATC
levomepromazine; systemic
2.7
7.2
46
173
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
7.2
128
758
M79.6
ICD-10 Finland
Pain in limb
1.5
7.2
323
2429
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.0
431
3447
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.5
7.0
50
203
T82
ICPC
Obesity
3.0
7.0
38
131
J01MA12
ATC
levofloxacin; systemic
1.6
7.0
173
1129
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.9
155
986
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
6.9
77
386
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.3
6.8
32
99
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.8
358
2771
L21
ICD-10 Finland
Seborrhoeic dermatitis
4.6
6.8
22
49
S70
ICPC
Herpes zoster
3.4
6.8
31
94
N03AX09
ATC
lamotrigine; oral
2.4
6.8
52
219
H65.0
ICD-10 Finland
Acute serous otitis media
4.7
6.7
21
45
D01AC02
ATC
miconazole; topical
2.1
6.7
76
382
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
6.7
137
848
H70.0
ICD-10 Finland
Acute mastoiditis
22.7
6.7
9
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
6.6
47
190
T90
ICPC
Diabetes non-insulin dependent
1.6
6.6
205
1417
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
6.6
75
379
ZXA05
NOMESCO Finland
Left side
1.5
6.6
221
1554
WX002
NOMESCO Finland
Sedation and analgesia
1.6
6.5
175
1167
Z2446
NOMESCO Finland
Social worker
2.2
6.5
65
311
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
6.5
52
224
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
6.5
84
445
E66.8
ICD-10 Finland
Other obesity
2.4
6.4
53
232
WX110
NOMESCO Finland
Local anesthesy
1.4
6.4
643
5584
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
70.3
6.4
7
*
J01DA06
ATC
[U] cefuroxime; systemic
1.7
6.4
136
850
A10BA02
ATC
metformin; oral
1.5
6.4
244
1763
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.8
6.4
39
145
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
6.4
104
599
H92.0
ICD-10 Finland
Otalgia
2.6
6.4
45
181
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.3
124
756
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
6.3
42
164
R51.80
ICD-10 Finland
Headache
1.7
6.3
122
743
J01AA02
ATC
doxycycline; systemic
1.4
6.3
743
6641
S18
ICPC
Laceration/cut
1.4
6.2
375
2966
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
6.2
179
1213
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
6.2
37
135
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
6.2
103
597
N03AX16
ATC
pregabalin; oral
1.5
6.2
209
1467
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.2
520
4365
J01FA09
ATC
clarithromycin; systemic
1.5
6.2
283
2126
H71
ICD-10 Finland
Cholesteatoma of middle ear
5.4
6.2
17
32
SPAT1260
SPAT
Consultation of another employee
1.6
6.2
161
1066
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.2
219
1557
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.8
6.1
36
130
C03CA01
ATC
furosemide; systemic
1.5
6.1
232
1674
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
4.7
6.1
19
41
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
6.1
60
285
H70.1
ICD-10 Finland
Chronic mastoiditis
12.6
6.1
10
8
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.1
198
1382
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
366
2897
J01FA06
ATC
roxithromycin; oral
1.4
6.0
368
2918
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.2
6.0
17
33
N06AX16
ATC
venlafaxine; oral
1.7
6.0
121
743

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
355
1058
4.41
108.42
2.3
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
529
2559
2.98
70.48
4.4
4.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
679
4835
1.99
27.70
7.7
5.9
e9/l
0.2
0.2
1.21
596
4285
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1089
9461
3.89
26.37
21.9
13.9
mg/l
25.3
24.1
0.75
1001
7473
(3001604) Monocytes [#/volume] in Blood
650
4662
1.91
24.80
7.2
5.6
e9/l
0.6
0.6
1.21
576
4052
(3013650) Neutrophils [#/volume] in Blood by Automated count
726
5406
1.93
24.62
12.4
9.0
e9/l
4.2
4.1
0.50
644
4757
(3000494) Fungus identified in Specimen by Culture
229
1141
2.26
24.36
2.0
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
650
4681
1.89
24.28
7.3
5.6
e9/l
0.0
0.0
0.58
572
4073
(3019198) Lymphocytes [#/volume] in Blood
659
4785
1.88
23.80
7.4
5.7
e9/l
1.9
2.0
0.53
587
4237
(3013826) Glucose [Moles/volume] in Serum or Plasma
719
5506
1.82
20.44
5.4
4.9
mmol/l
6.8
6.7
0.36
682
5161
(42870588) Differential panel, method unspecified - Blood
466
3141
1.81
20.37
7.1
5.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
366
2319
1.85
19.38
9.2
6.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1090
9760
3.27
19.26
23.5
15.9
mmol/l
139.6
139.7
0.23
1065
9504
(3042936) Bacteria identified in Isolate by Culture
248
1396
1.99
18.72
2.4
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1090
9793
3.20
18.48
23.7
16.0
mmol/l
4.0
4.0
0.56
1063
9526
(3022096) Basophils/100 leukocytes in Blood
579
4241
1.74
18.40
7.4
5.8
%
0.7
0.7
0.91
543
3981
(3019069) Monocytes/100 leukocytes in Blood
596
4404
1.73
18.33
7.8
6.1
%
8.6
8.6
0.01
561
4148
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
565
4115
1.73
18.29
6.8
6.2
mmol/l
1.2
1.2
0.05
524
3755
(3006504) Eosinophils/100 leukocytes in Blood
592
4384
1.72
17.91
7.4
5.8
%
3.1
2.9
1.39
553
4103
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
516
3706
1.71
17.24
2.2
2.0
pmol/l
94.1
94.8
0.11
293
1945
(3002030) Lymphocytes/100 leukocytes in Blood
602
4510
1.70
17.18
7.6
5.9
%
27.1
27.9
1.09
563
4224
(3018010) Neutrophils/100 leukocytes in Blood
595
4449
1.70
17.06
7.3
5.7
%
57.5
57.2
0.28
557
4189
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
605
4566
1.69
16.57
8.5
6.9
mmol/l
1.2
1.2
0.39
517
3864
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
869
7274
1.80
15.94
9.5
7.6
u/l
81.7
77.5
0.76
819
6839
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
246
1464
1.87
15.42
2.1
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
531
3951
1.64
14.76
6.3
4.9
g/l
35.2
35.6
0.86
499
3686
(3000991) Gas panel - Venous blood
146
738
2.12
14.56
7.3
8.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
980
8632
1.92
13.74
5.2
4.6
mu/l
2.2
1.9
0.63
896
7928
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
316
2091
1.71
13.59
1.6
1.7
mg/l
1.0
1.1
0.46
243
1585
(3033658) Prothrombin time (PT) actual/Normal
345
2339
1.68
13.54
4.5
3.8
%
89.3
90.6
0.43
335
2284
(3032080) INR in Blood by Coagulation assay
503
3768
1.60
13.10
10.9
9.3
inr
1.2
1.2
0.60
138
1099
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
628
4958
1.59
13.05
7.1
6.4
umol/l
12.3
11.5
0.29
601
4704
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
332
2252
1.67
12.90
2.6
2.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
742
6102
1.61
12.90
5.1
4.3
e6/l
1808.0
2156.8
—
5
99
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
26
52
5.09
12.45
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
229
1421
1.76
12.25
1.9
2.1
s
29.5
29.7
0.17
221
1379
(3013707) Erythrocyte sedimentation rate by Westergren method
816
6930
1.61
11.81
4.8
4.0
mm/h
14.1
11.9
4.26
760
6425
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
839
7179
1.63
11.72
4.3
3.9
pmol/l
14.5
14.8
3.24
776
6554
(3044640) Blood type and Crossmatch panel - Blood
405
2947
1.58
11.57
2.8
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
241
1544
1.71
11.44
2.8
2.7
e6/l
1.0
1.1
0.07
146
876
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
112
561
2.10
11.39
1.4
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
765
6432
1.57
11.25
5.0
4.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
89
410
2.27
11.14
3.3
3.6
mmol/l
24.2
24.2
0.08
80
369
(3019309) Folate [Moles/volume] in Red Blood Cells
251
1643
1.68
10.95
1.7
1.7
nmol/l
1242.6
1196.6
0.30
187
1252
(3015377) Calcium [Moles/volume] in Serum or Plasma
416
3077
1.55
10.91
3.6
3.5
mmol/l
2.4
2.4
0.28
365
2713
(3011397) Hemoglobin [Presence] in Urine by Test strip
305
2114
1.60
10.54
4.2
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
374
2718
1.56
10.54
3.8
3.3
mg/l
521.0
287.9
0.40
254
1757
(3021960) Folate [Moles/volume] in Serum or Plasma
306
2123
1.60
10.53
1.6
1.5
nmol/l
18.9
20.6
1.09
256
1809
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
979
8797
1.76
10.49
6.7
5.6
mmol/mol
41.0
39.7
3.24
881
8189
(3018418) pH of Serum or Plasma
372
2704
1.56
10.46
4.6
4.1
ph
7.4
7.4
0.32
64
528
(3002032) Base excess in Venous blood by calculation
146
829
1.87
10.37
4.5
3.5
mmol/l
1.8
2.1
0.45
122
656
(3007461) Platelets [#/volume] in Blood
1120
10590
3.28
10.14
31.6
20.3
e9/l
249.3
249.9
0.13
1101
10328
(3022948) Iron [Moles/volume] in Serum or Plasma
222
1435
1.68
10.08
3.0
2.4
umol/l
12.3
13.5
1.77
200
1330
(3009508) Creatinine [Moles/volume] in Urine
393
2914
1.53
10.00
3.7
3.2
mmol/l
7.6
7.8
0.27
334
2454
(3035941) MCH [Entitic mass]
1120
10597
3.25
9.99
31.5
20.2
pg
30.3
30.4
0.89
1111
10444
(3024731) MCV [Entitic volume]
1120
10597
3.25
9.99
31.5
20.2
fl
91.0
91.0
0.11
1111
10444
(3026361) Erythrocytes [#/volume] in Blood
1120
10598
3.25
9.97
31.6
20.3
e12/l
4.5
4.5
1.64
1099
10311
(3010813) Leukocytes [#/volume] in Blood
1120
10599
3.25
9.94
31.7
20.3
e9/l
7.0
6.7
5.19
1099
10309
(3003396) Base excess in Arterial blood by calculation
172
1042
1.77
9.86
6.2
8.6
mmol/l
0.8
1.2
0.66
130
816
(3000963) Hemoglobin [Mass/volume] in Blood
1120
10603
3.23
9.86
31.8
20.4
g/l
134.5
136.3
3.62
1111
10447
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
321
2287
1.56
9.74
2.5
2.1
mg/l
3.0
3.0
0.01
279
1952
(40761511) CBC panel - Blood by Automated count
1071
9950
2.13
9.67
19.4
13.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
171
1045
1.75
9.50
6.3
8.5
kpa
11.7
12.2
0.76
160
1009
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
171
1045
1.75
9.50
6.3
8.5
kpa
5.1
5.1
0.43
159
1006
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
194
1228
1.70
9.50
3.1
2.4
%
21.6
23.9
1.49
164
1057
(3004789) Transferrin [Mass/volume] in Serum or Plasma
206
1326
1.67
9.47
3.0
2.4
g/l
2.3
2.3
0.29
186
1232
(3012095) Magnesium [Moles/volume] in Serum or Plasma
229
1515
1.64
9.46
4.1
3.4
mmol/l
0.8
0.8
0.98
214
1426
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
136
785
1.83
9.15
2.3
2.4
ug/l
8.7
7.3
0.29
123
706
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
462
3594
1.48
9.11
4.6
3.5
ng/l
33.6
39.8
0.53
328
2461
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
989
8994
1.72
9.11
18.1
12.6
ml/min/173m2
81.6
82.0
0.21
865
7433
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
167
1028
1.73
9.03
1.9
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
187
1189
1.68
8.98
7.6
5.7
mmol/l
1.1
1.0
1.00
178
1114
(3021589) Normoblasts [#/volume] in Blood
520
4149
1.46
8.96
12.1
9.3
e9/l
0.0
0.0
0.12
431
3425
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
119
665
1.88
8.86
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
167
1034
1.72
8.83
1.9
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
28
5.78
8.82
1.1
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
345
2551
1.50
8.65
3.3
3.0
e6/l
0.5
0.5
0.16
270
1906
(3037522) Nuclear Ab [Titer] in Serum
193
1249
1.66
8.64
1.4
1.3
titre
817.8
488.1
0.96
45
256
(3020682) Albumin/Creatinine [Ratio] in Urine
381
2877
1.49
8.61
4.2
4.0
mg/mmol
9.5
8.8
0.16
260
1836
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
702
5967
1.45
8.44
3.1
2.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
135
798
1.78
8.38
9.1
7.6
mmol/l
11.0
9.6
1.27
129
760
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
100
539
1.94
8.30
1.8
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1081
10154
2.09
8.24
13.9
10.2
u/l
28.5
26.9
1.85
1044
9817
(3016502) Oxygen saturation in Arterial blood
152
936
1.72
8.18
6.6
9.0
%
95.9
95.7
0.25
146
906
(3022217) INR in Platelet poor plasma by Coagulation assay
178
1150
1.65
7.99
35.2
23.8
inr
1.1
1.2
1.35
17
160
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
174
1119
1.65
7.95
10.2
7.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
133
795
1.76
7.95
6.5
7.5
mmol/l
1.4
1.3
0.39
126
767
(3020891) Body temperature
73
360
2.10
7.76
4.6
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
405
3148
1.44
7.69
3.6
3.3
u/l
34.7
32.9
0.39
372
2991
(3018095) Leukocytes [#/volume] in Urine
417
3261
1.44
7.66
3.9
3.6
e6/l
51.2
110.2
1.32
296
2301
(36304419) Bacteria [Presence] in Urine
330
2476
1.47
7.52
3.3
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
742
6439
1.43
7.52
4.0
3.1
u/l
55.3
50.5
0.64
686
6038
(3026493) Urate [Moles/volume] in Serum or Plasma
331
2488
1.46
7.46
3.2
2.6
umol/l
4625.5
6544.6
0.31
287
2175
(40761535) Cells panel - Urine sediment
128
771
1.74
7.44
3.8
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
212
1454
1.56
7.40
2.8
2.9
e6/l
2.5
2.2
0.12
117
791
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
538
4426
1.41
7.33
4.2
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
350
2677
1.44
7.15
3.5
3.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
123
743
1.73
7.08
2.3
2.9
g/l
66.1
66.6
0.33
111
686
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
137
855
1.68
7.01
2.7
2.4
u/l
33.3
38.4
0.67
118
729
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
233
1651
1.52
6.98
3.2
3.1
mmol/l
2.5
2.4
1.61
200
1459
(40760892) CBC W Ordered Manual Differential panel - Blood
289
2140
1.47
6.97
5.2
4.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
342
2616
1.44
6.95
3.3
3.0
ng/l
1697.6
1267.7
1.06
294
2236
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
362
2806
1.42
6.81
2.3
2.1
u/l
159.2
231.2
1.43
347
2659
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
180
2.44
6.76
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
180
2.44
6.76
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
28
94
3.03
6.68
3.8
3.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
84
461
1.89
6.64
8.1
11.1
mmol/l
24.4
24.4
0.00
75
437
(3019060) Gas panel - Arterial blood
104
610
1.78
6.64
3.6
5.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
466
3787
1.39
6.62
2.6
2.2
nmol/l
73.7
76.4
1.30
429
3407
(3007566) Smooth muscle Ab [Titer] in Serum
54
253
2.19
6.57
1.4
1.2
titre
80.0
84.3
—
5
21
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
90
3.05
6.53
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
120
738
1.70
6.48
3.2
2.9
ng/l
246.0
198.8
0.44
110
678
(3005719) IgG [Mass/volume] in Serum or Plasma
117
717
1.70
6.40
2.7
2.7
g/l
10.0
10.7
1.37
108
662
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
155
1021
1.60
6.40
4.5
4.3
u/l
256.1
251.6
0.12
147
966
(3004588) Protein electrophoresis panel - Serum or Plasma
104
618
1.75
6.35
2.6
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
357
2798
1.40
6.20
3.5
3.1
e6/l
198.1
84.0
0.52
282
2142
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
243
1777
1.47
6.17
3.9
3.7
ng/l
1157.1
414.4
0.65
186
1361
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
19
5.84
6.11
1.2
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
889
8090
1.44
6.08
27.0
17.7
g/l
332.0
332.8
1.66
882
8034
(3035350) Ketones [Presence] in Urine by Test strip
545
4587
1.36
6.04
4.2
3.5
estimate
0.0
0.0
0.00
96
867
(3000850) Epithelial cells [#/volume] in Urine
259
1928
1.44
5.98
2.7
2.5
e6/l
7.4
5.4
0.62
230
1699
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
993
9248
1.54
5.92
5.4
4.5
mmol/l
6.2
5.9
4.28
905
8457
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
262
1965
1.43
5.79
1.6
1.7
pmol/l
29302759.4
26399452.5
0.03
215
1644
(3036481) Cortisol [Moles/volume] in Serum or Plasma
133
865
1.61
5.78
2.8
2.2
nmol/l
357.7
368.6
0.31
125
801
(3035637) Corticotropin [Mass/volume] in Plasma
27
97
2.83
5.76
1.9
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
155
1047
1.56
5.74
1.8
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
53
262
2.07
5.66
3.5
3.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
17
5.93
5.63
1.0
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
868
7908
1.40
5.54
24.2
16.8
%
13.8
13.6
2.97
861
7749
(3005322) IgE [Units/volume] in Serum or Plasma
97
591
1.70
5.44
1.3
1.2
u/ml
703.9
216.0
1.56
89
550
(3021601) Nitrite [Presence] in Urine by Test strip
541
4596
1.33
5.44
5.7
4.8
estimate
0.0
0.0
0.50
94
876
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
333
1.91
5.27
2.2
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
35
4.04
5.18
1.2
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1024
9662
1.55
5.08
5.4
4.8
mmol/l
2.7
2.8
4.00
937
8930
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
367
1.85
5.06
2.5
2.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
69
390
1.82
5.02
1.9
2.0
ug/l
6.1
1.9
0.52
55
356
(4034850)
56
297
1.93
4.96
7.5
10.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
93
576
1.67
4.92
1.6
1.8
g/l
1.0
1.4
2.95
84
539
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
369
2997
1.34
4.92
2.9
2.6
u/l
65.4
57.7
0.45
348
2779
(3009261) Glucose [Presence] in Urine by Test strip
541
4641
1.31
4.90
4.2
3.6
estimate
0.0
0.0
0.80
92
843
(3024928) Oxygen saturation in Venous blood
42
203
2.11
4.80
2.0
2.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
324
1.87
4.72
2.5
2.5
g/l
9.7
10.4
0.84
47
281
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
973
9115
1.44
4.71
4.4
3.9
mmol/l
1.4
1.3
3.47
882
8399
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
64
362
1.81
4.66
5.7
3.8
mmol/l
24.9
24.9
0.02
58
342
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
38
3.72
4.65
1.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
349
1.82
4.59
2.5
2.4
g/l
4.3
3.8
0.60
43
258
(3008152) Bicarbonate [Moles/volume] in Arterial blood
93
587
1.64
4.59
6.3
8.0
mmol/l
24.0
24.5
0.61
87
550
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
11
8.24
4.56
1.0
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
350
1.82
4.55
2.5
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
350
1.82
4.55
2.5
2.4
g/l
7.4
7.4
0.09
45
269
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
21
4.79
4.53
1.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
104
678
1.59
4.50
4.8
3.9
ng/l
110.4
84.7
1.30
95
607
(3024891) Influenza virus A+B Ag [Presence] in Specimen
47
243
1.97
4.50
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
91
576
1.63
4.45
1.2
1.3
au/ml
16.5
43.5
—
5
27
(3026782) Osmolality of Urine
236
1814
1.38
4.43
2.8
2.7
mosm/kgh2o
555.2
553.2
0.05
205
1557
(4010399)
101
657
1.59
4.42
1.5
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
26
4.26
4.36
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
935
8731
1.38
4.33
22.1
14.7
%
40.0
40.1
0.08
667
6336
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
328
1.81
4.25
2.5
2.5
g/l
3.1
3.1
0.03
43
262
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
87
552
1.62
4.22
5.4
3.4
mmol/l
1.8
1.8
0.02
69
417
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
57
3.01
4.13
1.1
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1003
9497
1.44
4.12
4.9
4.4
mmol/l
4.5
4.7
6.83
922
8836
(3003327) Ova and parasites identified in Stool by Light microscopy
54
302
1.83
4.11
1.5
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
23
4.38
4.09
1.6
2.3
umol/l
16.7
18.6
—
10
23
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
209
1596
1.38
4.07
1.6
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
70
424
1.69
4.06
5.6
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
150
1081
1.45
4.06
2.5
2.7
umol/l
12.3
8.5
0.42
129
943
(3001122) Ferritin [Mass/volume] in Serum or Plasma
470
4030
1.28
4.02
3.4
2.7
ug/l
132.4
135.6
0.10
428
3737
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
90
583
1.59
4.02
5.5
3.4
kpa
5.3
5.2
1.19
84
546
(3009343) pH of Capillary blood
89
575
1.59
4.02
5.4
3.4
ph
7.4
7.4
0.61
12
75
(3007164) IgA [Mass/volume] in Serum or Plasma
231
1796
1.36
4.01
1.5
1.5
g/l
2.6
2.5
0.24
141
1137
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
396
1.71
3.97
1.9
2.1
g/l
1.7
1.5
0.45
56
345
(3044889) 12 lead EKG panel
735
6666
1.28
3.97
4.4
3.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
257
2041
1.33
3.87
1.4
1.2
u/ml
2.4
1.7
0.28
68
568
(3019150) Specific gravity of Urine by Refractometry
258
2055
1.33
3.80
5.0
3.9
kg/l
1.0
1.0
0.24
33
288
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
996
9447
1.41
3.78
4.8
4.3
mmol/l
1.4
1.5
13.02
914
8732
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
260
1.84
3.73
1.6
1.5
ug/g
241.0
281.7
0.61
28
155
(46235355) HIV 1 and 2 tests - Meaningful Use set
205
1585
1.36
3.68
2.1
1.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
97
2.40
3.66
1.3
1.3
e6/l
14350.9
104261.0
0.76
14
72
(40768804) Tissue Pathology biopsy report
434
3718
1.27
3.65
2.1
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
135
977
1.43
3.58
4.7
3.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
9
7.82
3.56
1.0
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
52
302
1.76
3.54
1.9
2.8
g/l
0.9
1.1
0.13
44
271
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
26
3.87
3.52
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
36
3.36
3.48
1.0
1.2
—
—
—
0
0
(4198724)
12
36
3.36
3.48
2.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
99
679
1.50
3.46
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
109
763
1.47
3.44
2.1
2.7
ml/min/173m2
67.8
66.3
0.15
47
301
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
100
2.33
3.44
2.7
4.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
121
866
1.44
3.41
2.7
2.2
g/l
0.2
0.2
0.04
111
809
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
276
1.77
3.39
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
50
291
1.75
3.39
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
95
2.34
3.35
1.1
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
110
776
1.46
3.35
3.8
4.1
%
0.8
1.0
0.50
41
233
(3019225) pH of Specimen
123
887
1.43
3.33
6.1
4.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
7
8.61
3.26
1.8
1.4
ng/l
130.7
93.1
—
6
7
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
55
333
1.68
3.25
2.6
2.3
ug/l
559.5
436.4
0.17
50
315
(3021440) Promyelocytes/100 leukocytes in Blood
104
732
1.46
3.21
3.6
4.2
%
0.1
0.1
0.24
37
210
(3002619) Bacteria identified in Specimen by Culture
8
15
5.36
3.19
1.5
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
136
1007
1.40
3.18
2.9
2.7
%
1.8
1.8
0.14
120
911
(3014765) Yersinia sp identified in Stool by Organism specific culture
49
290
1.72
3.15
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
67
2.56
3.13
3.9
2.1
e6/l
644.0
741.5
—
7
27
(3002179) Metamyelocytes/100 leukocytes in Blood
100
703
1.46
3.11
3.4
4.0
%
1.0
0.4
1.31
33
166
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
306
2560
1.27
3.05
1.7
1.7
mmol/l
1.5
1.4
1.48
257
2142
(42529406) Shigella sp [Presence] in Stool by Culture
49
293
1.70
3.05
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
139
1043
1.38
3.01
2.0
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
42
241
1.77
3.01
2.1
1.7
e6/l
10210.1
15015.3
0.58
30
181
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
100
2.22
3.01
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
47
279
1.71
3.00
1.7
2.5
g/l
38.1
37.7
0.22
40
246
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
47
279
1.71
3.00
1.7
1.6
iu/ml
0.3
0.1
0.64
14
48
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
264
1.73
3.00
1.7
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
5
10.04
2.98
1.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
94
2.26
2.97
2.0
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
48
288
1.70
2.95
2.9
2.5
u/ml
0.3
0.4
2.12
28
155
(3013512) EKG study
319
2693
1.26
2.93
5.1
3.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
76
2.39
2.90
2.4
2.2
e9/l
1.0
1.1
—
8
43
(3035320) C reactive protein [Mass/volume] in Body fluid
17
70
2.45
2.88
3.5
2.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
89
2.27
2.88
2.9
3.9
%
60.5
53.2
0.71
15
66
(3025159) Blasts/100 leukocytes in Blood
97
689
1.45
2.88
3.7
4.2
%
0.0
0.6
0.66
33
177
(40768797) Stomach Pathology biopsy report
169
1320
1.33
2.83
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
110
2.11
2.80
1.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
73
493
1.51
2.78
7.9
11.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
167
1.88
2.73
1.3
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
98
2.16
2.72
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
54
2.61
2.71
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
54
2.61
2.71
1.1
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
96
689
1.43
2.70
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
409
3576
1.22
2.68
4.5
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
137
1047
1.35
2.66
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
252
1.69
2.62
1.5
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
25
3.62
2.57
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
88
2.18
2.52
2.9
2.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
36
210
1.74
2.49
4.9
3.4
umol/l
42.3
35.6
0.72
31
173
(3000093) Morphology [Interpretation] in Blood Narrative
17
76
2.26
2.45
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
51
2.57
2.45
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
189
1.77
2.43
8.7
6.3
iu/ml
242.1
363.2
—
10
29
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
377
3300
1.21
2.40
4.6
4.8
ug/l
3.0
2.4
0.40
328
2967
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
145
1136
1.32
2.39
4.9
4.4
%
31.4
31.8
0.19
102
783
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
97
2.08
2.38
1.1
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
66
455
1.48
2.32
2.6
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
310
3568
0.82
2.32
2.9
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
105
2.02
2.31
1.4
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
194
1.72
2.24
2.3
2.2
g/l
134.5
130.1
0.48
23
145
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
86
2.11
2.23
1.6
1.4
%
32.4
32.2
—
10
61
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
196
1614
1.26
2.20
1.3
1.3
iu/ml
19.3
37.4
2.52
49
494
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
13
54
2.42
2.20
1.1
1.3
—
91.3
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
26
143
1.84
2.20
5.1
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
163
1313
1.28
2.20
1.9
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
67
2.26
2.18
1.3
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
14
4.30
2.15
1.0
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
183
1.71
2.09
1.1
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
99
749
1.35
2.09
3.1
2.8
e9/l
66.6
70.5
0.68
78
589
(3029937) Albumin [Presence] in Urine by Test strip
289
2495
1.21
2.09
4.7
3.8
estimate
0.0
0.0
0.88
92
850
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
285
1.57
2.08
3.6
3.8
mg/l
30.4
31.2
0.05
39
236
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
89
2.04
2.06
2.1
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
246
1.61
2.06
3.8
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
45
294
1.55
2.06
3.6
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
20
3.51
2.05
1.3
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
56
2.34
2.05
1.5
2.0
%
16.8
15.7
—
8
25
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
15
4.02
2.04
1.3
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
50
2.41
2.03
1.2
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
38
2.65
2.01
1.1
1.2
%
—
68.8
—
0
5
(40768443) Skin Pathology biopsy report
57
395
1.47
1.99
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
38
241
1.60
1.97
1.2
1.2
u/ml
2.6
9.8
—
5
38
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
120
1.85
1.93
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
148
1198
1.27
1.93
1.3
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
33
2.74
1.93
1.2
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
45
2.46
1.93
3.9
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
174
1.68
1.87
1.7
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
49
334
1.49
1.87
1.6
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
28
2.87
1.86
3.6
2.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
31
190
1.65
1.85
1.1
1.2
u/ml
42.3
44.2
—
8
16
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
17
3.54
1.84
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
17
3.54
1.84
1.0
1.2
%
115.8
98.3
—
6
17
(3010375) cycloSPORINE [Mass/volume] in Blood
10
40
2.51
1.84
42.5
31.2
ug/l
86.6
124.8
—
10
30
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
199
1.63
1.82
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
23
3.06
1.80
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
23
3.06
1.80
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
47
321
1.48
1.79
3.7
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
23
131
1.77
1.78
1.5
1.4
nmol/l
0.3
0.3
0.00
16
101
(3003181) Sodium [Moles/volume] in Urine
27
162
1.68
1.76
1.2
1.3
mmol/l
52.6
62.2
0.73
20
138
(3051593) INR in Capillary blood by Coagulation assay
10
41
2.45
1.75
1.1
9.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
81
1.99
1.75
1.6
1.3
g/l
6.6
6.9
—
9
56
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
81
1.99
1.75
1.6
1.3
g/l
0.5
0.3
—
9
56
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
81
1.99
1.75
1.6
1.3
g/l
3.5
2.7
—
10
54
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
298
1.50
1.75
1.3
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
18
3.35
1.75
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
182
1527
1.23
1.74
1.2
1.3
u/ml
6.2
12.6
1.10
61
605
(3000764) Benzodiazepines [Presence] in Urine
47
323
1.47
1.74
3.5
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.86
1.71
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
149
1226
1.25
1.71
2.3
1.8
%
1.5
1.5
0.11
141
1072
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
48
2.30
1.70
1.0
2.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
187
1.62
1.70
1.2
1.2
u/ml
192.0
263.5
0.85
18
116
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
172
1.64
1.68
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
55
2.19
1.67
1.3
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
47
326
1.46
1.67
3.6
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
25
2.81
1.65
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
83
1.94
1.65
4.2
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
46
319
1.46
1.64
3.4
3.8
g/l
0.6
0.2
0.85
21
135
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
158
1.66
1.63
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
71
533
1.35
1.62
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
166
1.64
1.62
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
98
1.85
1.62
2.4
2.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
56
2.15
1.61
1.4
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
56
2.15
1.61
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
190
1.59
1.61
1.6
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
113
1.78
1.61
1.6
1.6
%
51.6
59.3
—
10
79
(3048689) Calprotectin [Mass/mass] in Stool
136
1116
1.25
1.61
3.0
2.3
ug/g
131.4
127.7
0.03
115
887
(3027273) Bicarbonate [Moles/volume] in Venous blood
61
448
1.38
1.60
6.1
3.3
mmol/l
24.6
25.3
0.97
61
437
(4062490)
16
84
1.92
1.60
1.6
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
62
457
1.38
1.59
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
26
2.70
1.58
1.9
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
26
2.70
1.58
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
29
184
1.59
1.55
3.0
2.5
%
17.7
16.3
1.11
15
93
(3037756) Immunofixation for Serum or Plasma
31
200
1.57
1.55
1.6
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
145
1.67
1.55
1.5
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
55
400
1.39
1.54
1.7
1.5
—
9.2
—
0
12
(3051387) C reactive protein [Mass/volume] in Capillary blood
10
206
0.48
1.54
2.3
3.6
mg/l
21.7
25.2
—
5
128
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
93
1.84
1.52
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
27
2.60
1.51
1.6
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
46
325
1.43
1.51
3.6
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
108
1.77
1.51
2.1
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
51
2.17
1.51
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
79
1.91
1.49
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
101
1.79
1.49
2.1
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
20
116
1.74
1.49
1.1
1.3
—
0.5
—
0
13
(3021387) Prolactin [Units/volume] in Serum or Plasma
43
302
1.44
1.46
1.7
1.5
mu/l
342.1
289.3
0.32
38
277
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
561
1.32
1.45
2.5
3.3
pmol/l
4.4
4.6
0.58
68
499
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
52
2.13
1.44
1.5
2.1
—
—
—
0
0
(4035726)
100
803
1.27
1.44
1.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
59
2.04
1.43
4.4
4.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
33
222
1.50
1.39
1.7
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
111
1.72
1.39
1.1
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
214
1.51
1.39
4.4
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
294
2632
1.16
1.36
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
24
152
1.59
1.32
2.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
34
2.36
1.29
1.5
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
286
1.41
1.27
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
31
211
1.48
1.26
3.6
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
203
1.49
1.25
1.2
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
22
139
1.59
1.23
1.8
1.6
g/l
0.8
0.8
0.04
15
106
(40768795) Lymph node Pathology biopsy report
15
85
1.77
1.23
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
108
1.68
1.22
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
191
1.48
1.14
1.7
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
43
318
1.37
1.14
2.6
2.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
40
293
1.38
1.13
2.3
1.7
nmol/l
40.0
39.7
0.02
35
283
(3000492) Spirometry study
113
949
1.21
1.12
1.7
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
31
2.27
1.10
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
21
2.39
1.09
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
144
1.54
1.09
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
41
1.96
1.09
2.3
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
41
1.96
1.09
2.3
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
293
2665
1.13
1.07
4.1
4.1
%
20.5
20.9
0.19
126
1236
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
74
1.77
1.07
1.2
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
37
271
1.38
1.06
1.6
2.3
%
191.7
187.9
0.11
37
260
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
307
1.35
1.03
1.5
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
11
60
1.84
1.03
1.7
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
68
1.77
1.00
1.2
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
68
1.77
1.00
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
48
1.88
1.00
2.2
2.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
174
1.45
0.95
2.2
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
18
117
1.55
0.94
1.1
1.3
nmol/l
0.6
0.6
0.06
18
111
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
55
1.83
0.92
1.3
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
39
296
1.33
0.92
2.3
2.1
%
92.4
91.1
0.13
39
279
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
159
1.46
0.91
1.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
29
2.07
0.89
6.5
4.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
29
2.07
0.89
2.2
2.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
177
1.42
0.89
1.4
1.4
u/ml
75.8
106.6
—
8
35
(3017732) Neutrophils [#/volume] in Blood
77
641
1.22
0.87
4.1
3.0
e9/l
4.9
4.1
1.08
54
516
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
103
1.56
0.87
1.1
1.3
nmol/l
—
—
—
0
0
(4146454)
16
103
1.56
0.87
2.9
2.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
20
137
1.47
0.84
4.5
2.7
u/ml
10.5
35.6
0.41
20
130
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
45
1.78
0.84
1.5
3.0
u/ml
846.3
1439.8
—
8
45
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
240
1.34
0.83
2.0
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
49
606
0.80
0.79
2.4
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
49
393
1.26
0.79
1.6
1.3
iu/l
28.4
30.7
0.17
41
338
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
8
48
1.67
0.79
1.1
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
82
1.59
0.78
1.5
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
213
1940
1.12
0.78
2.8
3.0
ug/l
0.8
0.7
0.06
139
1245
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
45
359
1.26
0.77
2.1
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
75
1.61
0.75
1.9
1.9
%
13.9
10.9
2.52
12
75
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
38
1.85
0.73
1.0
1.0
—
15.0
—
0
7
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
39
1.80
0.72
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
92
1.53
0.72
1.2
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
56
1.61
0.72
1.2
1.3
ug/l
5.2
5.9
—
9
45
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
84
1.55
0.72
1.2
1.3
e6/l
481256.7
106224.0
—
6
48
(3047181) Lactate [Moles/volume] in Blood
38
301
1.27
0.70
3.8
8.0
mmol/l
1.3
1.3
0.05
33
269
(3019832) Treponema pallidum Ab [Presence] in Serum
86
743
1.17
0.69
1.8
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
42
1.67
0.68
9.3
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
3.1
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
42
1.67
0.68
3.1
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
3.1
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
127
1.42
0.68
3.3
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
153
1.38
0.67
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
119
1.44
0.67
1.9
2.4
pg
33.1
32.6
0.25
17
119
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
51
421
1.22
0.67
1.7
2.0
u/l
37.5
39.1
0.27
44
378
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
162
1.37
0.66
5.0
2.6
—
—
—
0
0
(4281824)
5
95
0.52
0.66
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
59
495
1.20
0.66
1.5
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
7
44
1.59
0.65
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
233
1.30
0.65
2.1
1.7
—
—
—
0
0
(3010421) pH of Blood
31
242
1.29
0.64
4.7
3.8
ph
7.4
7.4
1.29
26
199
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
87
759
1.16
0.63
2.7
2.2
nmol/l
11.1
13.2
1.64
74
685
(3021901) Oxygen saturation in Capillary blood
22
164
1.35
0.62
4.8
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
96
1.46
0.61
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
96
1.46
0.61
2.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
96
1.46
0.61
2.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
51
1.57
0.60
1.6
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
105
1.43
0.60
2.0
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.6
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
246
1.27
0.58
1.3
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
1.6
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
89
1.47
0.58
1.7
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
202
1.29
0.57
5.2
4.1
mmol/l
2.5
2.5
0.00
20
139
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
2.9
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
2.9
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
2.9
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
55
1.46
0.56
2.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
55
1.46
0.56
2.4
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
212
1.28
0.56
1.2
1.4
e6/l
2.9
48.4
0.96
22
166
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
125
1380
0.89
0.55
1.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
133
1.36
0.55
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
195
1.29
0.54
3.5
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
204
1.28
0.54
1.5
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
60
1.50
0.54
1.6
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
74
1.49
0.53
2.0
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
62
1.46
0.53
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
91
1.43
0.53
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
91
1.43
0.53
1.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
40
1.50
0.51
1.2
2.2
ug/l
16.6
228.6
—
6
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
144
1.32
0.50
1.6
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
65
1.39
0.50
1.4
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
136
1.33
0.49
1.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
172
1.28
0.48
1.5
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
46
1.52
0.48
2.4
2.6
%
98.0
103.2
—
7
46
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
86
768
1.13
0.48
6.5
3.6
mmol/l
1.2
1.2
0.12
78
669
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
272
1.22
0.47
2.8
2.1
u/l
18700.1
2738.2
—
9
114
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
365
0.82
0.47
1.7
1.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
85
1.42
0.47
2.4
2.2
—
2.1
—
0
6
(3004716) Salmonella sp identified in Stool by Organism specific culture
57
496
1.16
0.46
1.5
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
142
0.70
0.46
1.6
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
2.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
2.6
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
86
1.40
0.44
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
247
1.22
0.44
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
285
1.20
0.43
1.1
1.3
miu/ml
364.7
229.0
0.85
12
133
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
304
1.19
0.42
1.6
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
87
1.38
0.42
1.2
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
57
1.41
0.42
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
6.7
—
0
16
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
53
603
0.87
0.41
1.5
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
34
1.47
0.40
3.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
50
437
1.15
0.40
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
97
1.34
0.39
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
104
0.67
0.39
1.1
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
106
1.32
0.39
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
458
1.14
0.38
2.4
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
136
0.73
0.37
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
43
374
1.16
0.37
3.1
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
107
1.31
0.37
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
161
1.25
0.37
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
189
1.22
0.36
3.3
3.8
%
57.0
56.5
0.09
23
189
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
949
1.09
0.35
2.1
2.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
99
1.32
0.35
1.2
1.2
u/l
45.3
54.4
—
8
68
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
154
1.24
0.34
1.5
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
136
1.25
0.33
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
182
1.21
0.33
3.1
3.4
e9/l
3.9
4.2
0.47
22
182
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
208
0.81
0.31
1.9
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
52
1.35
0.31
1.7
1.3
nmol/l
134.0
151.3
—
7
52
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
3.1
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
28
240
1.17
0.30
1.2
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
76
1.32
0.28
1.3
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
65
595
1.10
0.27
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
104
1.25
0.26
3.1
2.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
67
1.20
0.26
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
67
1.20
0.26
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
67
1.20
0.26
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
160
1.19
0.25
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
212
0.85
0.24
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
143
1.19
0.23
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
463
0.90
0.23
5.2
3.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
40
1.25
0.22
1.2
1.1
miu/ml
2797.8
1576.6
—
5
40
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
68
632
1.08
0.22
1.3
1.2
iu/ml
140.9
138.7
0.02
24
270
(40761536) Microorganisms panel - Urine sediment
85
798
1.07
0.22
4.3
3.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
42
1.19
0.21
1.2
1.1
—
19.8
—
0
6
(3045414) Leukocytes [Presence] in Urine
38
419
0.90
0.21
1.7
1.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
283
0.88
0.21
1.5
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
71.3
—
0
12
(44806118)
14
117
1.20
0.20
1.5
1.6
—
—
—
0
0
(44790047)
14
117
1.20
0.20
1.5
1.6
—
—
—
0
0
(44790049)
14
117
1.20
0.20
1.5
1.6
—
—
—
0
0
(44790048)
14
117
1.20
0.20
1.5
1.6
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
29.0
—
0
9
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
48
1.25
0.20
1.3
1.3
u/l
180.2
567.5
—
6
43
(21494755) Public health laboratory ask at order entry panel
92
970
0.94
0.19
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
163
0.86
0.17
1.6
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
67
0.75
0.17
1.4
1.2
—
—
—
0
0
(4094501)
28
253
1.11
0.17
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(4024509)
8
71
1.13
0.16
1.9
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
90
858
1.05
0.16
2.1
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
99
948
1.05
0.15
3.3
4.4
ug/l
6.0
27.8
1.58
74
792
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
87
0.80
0.14
2.0
3.8
u/ml
18.3
56.7
—
7
87
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
132
1.14
0.13
1.1
1.0
u/ml
1.3
2.9
—
5
36
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
219
1.10
0.12
1.8
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
85
1.18
0.12
1.8
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
133
1.13
0.12
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
137
0.87
0.12
1.1
1.0
u/ml
1.2
0.9
—
7
51
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
124
1.13
0.11
2.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
124
1.13
0.11
2.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
125
1.12
0.10
2.4
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
47
1.06
0.09
2.4
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
184
1.09
0.09
1.6
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
124
0.89
0.09
1.1
1.0
u/ml
17.0
3.2
—
5
45
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
126
1.11
0.09
2.4
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
55
1.09
0.09
1.3
1.1
u/l
14.7
16.0
—
6
46
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
57
1.05
0.08
1.3
1.1
u/l
95.5
74.5
—
6
49
(3016750) Collection duration of Urine
5
61
0.82
0.08
2.0
2.1
min
434.2
491.8
—
5
41
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
146
1.10
0.08
1.4
1.5
—
—
—
0
0
(44813793)
5
65
0.77
0.08
1.2
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
123
0.89
0.08
3.1
2.5
mmol/l
4.1
4.0
0.21
11
123
(3035285) Chloride [Moles/volume] in Venous blood
11
123
0.89
0.08
3.1
2.5
mmol/l
105.5
105.6
0.01
11
123
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
127
1.10
0.08
2.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
127
1.10
0.08
2.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
864
0.97
0.07
1.5
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
137
1.10
0.07
1.5
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
2.1
1.4
g/l
0.9
1.0
—
8
77
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
82
0.85
0.07
1.9
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
19
204
0.93
0.07
1.6
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
167
1.08
0.07
1.1
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
39
374
1.04
0.06
1.6
1.7
mg/l
7.0
2.5
0.61
28
266
(3025130) Human papilloma virus identified in Specimen
9
103
0.87
0.06
1.9
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
152
0.92
0.06
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
152
0.92
0.06
1.1
1.2
u/ml
1.2
3.8
—
5
43
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
121
0.91
0.06
3.1
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
33
316
1.05
0.05
1.6
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
19
202
0.94
0.05
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
110
0.91
0.05
1.2
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
110
1.09
0.05
1.1
1.1
u/ml
21.5
3.8
—
6
43
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
140
1.07
0.04
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
140
1.07
0.04
1.4
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
129
0.93
0.03
2.6
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
151
1.06
0.03
1.1
1.1
—
13.5
—
0
9
(3050129) First trimester maternal screen panel - Serum or Plasma
21
219
0.96
0.03
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
132
1.06
0.02
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
253
2543
0.99
0.02
3.7
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
90
890
1.01
0.02
1.7
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
153
1.05
0.01
1.1
1.2
u/ml
1.6
6.9
—
10
62
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
173
1.04
0.01
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
173
1.04
0.01
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
173
1.04
0.01
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
173
1.04
0.01
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
243
1.03
0.01
2.8
2.4
ug/min
134.0
100.9
0.23
17
148
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
236
0.97
0.00
1.7
1.8
iu/l
5.4
5.0
—
7
81
(1761482) Bacteria [#/volume] in Urine by Culture
24
246
0.98
0.00
7.0
4.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
144
0.97
0.00
1.1
1.0
u/ml
6.1
6.3
—
9
67
(4306422)
15
148
1.01
0.00
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
159
1.01
0.00
1.3
1.1
u/ml
7.0
2.0
—
9
61
(3008898) HLA-B27 [Presence]
35
349
1.00
0.00
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
105
1.05
0.00
1.8
1.3
—
—
—
0
0
(4268621)
9
97
0.93
0.00
2.0
2.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
52
0.96
0.00
7.6
3.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
54
0.93
0.00
1.4
2.6
ml
2084.0
2067.3
—
5
47
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
49
1.02
0.00
1.0
1.9
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
2.1
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
100.0
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
181.3
—
0
7
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
54
0.93
0.00
1.4
1.5
—
10.7
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
12.3
—
0
8
(3005570) Glucose [Moles/volume] in Urine
9
96
0.94
0.00
2.3
2.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
823.4
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
33.3
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXTDISINOTH and mortality.

Females

Parameter HR [95% CI] p-value
H8_EXTDISINOTH 1.404 [1.19, 1.66] < 0.001
Birth year 0.998 [0.99, 1.01] 0.619

During the follow-up period (1.1.1998 — 31.12.2019), 419 out of 2954 females with H8_EXTDISINOTH died.

Males

Parameter HR [95% CI] p-value
H8_EXTDISINOTH 1.515 [1.27, 1.8] < 0.001
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 517 out of 3092 males with H8_EXTDISINOTH died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXTDISINOTH.

N-year risk Females Males
1 0.167% 0.355%
5 0.973% 1.728%
10 2.414% 4.346%
15 4.32% 8.045%
20 7.788% 13.438%

Relationships between endpoints

↥

Index endpoint: H8_EXTDISINOTH – Disorder of external ear, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data